Natera, Inc.
Status: Publicly traded
Direct answer
Natera, Inc. is publicly traded on NASDAQ under the ticker NTRA.
Natera, Inc. is a diagnostics company focused on developing and commercializing a wide array of molecular testing services globally. Its portfolio includes several key offerings: Panorama, a non-invasive prenatal test (NIPT) that screens for chromosomal abnormalities in a fetus using a blood sample from the mother, and also determines zygosity in twin pregnancies. Vistara, designed to identify single-gene disorders...
Can you invest in Natera, Inc.?
Yes. Natera, Inc. is publicly traded on NASDAQ under the ticker NTRA.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Natera, Inc.
Detailed equity research is provided by MarketSnap.